Yao X - Search Results

1

Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease.

Tang W, Yao X, Xia F, Yang M, Chen Z, Zhou B, Liu Q. Tang W, et al. Among authors: yao x. Oxid Med Cell Longev. 2018 Dec 23;2018:7261619. doi: 10.1155/2018/7261619. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30671174 Free PMC article.

2

Hugan Qingzhi Exerts Anti-Inflammatory Effects in a Rat Model of Nonalcoholic Fatty Liver Disease.

Tang W, Zeng L, Yin J, Yao Y, Feng L, Yao X, Sun X, Zhou B. Tang W, et al. Among authors: yao y, yao x. Evid Based Complement Alternat Med. 2015;2015:810369. doi: 10.1155/2015/810369. Epub 2015 Jun 14. Evid Based Complement Alternat Med. 2015. PMID: 26146507 Free PMC article.

3

Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.

Zeng L, Tang W, Yin J, Feng L, Li Y, Yao X, Zhou B. Zeng L, et al. Among authors: yao x. Cell Physiol Biochem. 2016;40(3-4):453-464. doi: 10.1159/000452560. Epub 2016 Nov 25. Cell Physiol Biochem. 2016. PMID: 27889747 Free article.

4

[Effect of Hugan Qingzhi tablets on AMPK pathway activation and NF-κB-p65 protein expression in the liver of rats with nonalcoholic fatty liver disease].

Yao XR, Xia F, Tang WJ, Zhou BJ. Yao XR, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2017 Jan 20;37(1):56-62. doi: 10.3969/j.issn.1673-4254.2017.01.10. Nan Fang Yi Ke Da Xue Xue Bao. 2017. PMID: 28109099 Free PMC article. Chinese.

5

Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury.

Xia F, Yao X, Tang W, Xiao C, Yang M, Zhou B. Xia F, et al. Among authors: yao x. Front Pharmacol. 2017 Feb 28;8:99. doi: 10.3389/fphar.2017.00099. eCollection 2017. Front Pharmacol. 2017. PMID: 28293193 Free PMC article.

6

Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.

Yao X, Xia F, Tang W, Xiao C, Yang M, Zhou B. Yao X, et al. J Ethnopharmacol. 2018 Feb 15;212:208-215. doi: 10.1016/j.jep.2017.09.016. Epub 2017 Oct 13. J Ethnopharmacol. 2018. PMID: 29031784

7

Data for iTRAQ-based quantification of the effect of HuganQingzhi on non-alcoholic fatty liver disease in rats.

Yao X, Xia F, Tang W, Xiao C, Yang M, Zhou B. Yao X, et al. Data Brief. 2017 Oct 16;15:612-614. doi: 10.1016/j.dib.2017.10.027. eCollection 2017 Dec. Data Brief. 2017. PMID: 29085877 Free PMC article.

8

Hugan Qingzhi medication ameliorates free fatty acid-induced L02 hepatocyte endoplasmic reticulum stress by regulating the activation of PKC-δ.

Yang M, Chen Z, Xiang S, Xia F, Tang W, Yao X, Zhou B. Yang M, et al. Among authors: yao x. BMC Complement Med Ther. 2020 Dec 11;20(1):377. doi: 10.1186/s12906-020-03164-3. BMC Complement Med Ther. 2020. PMID: 33308192 Free PMC article.

9

Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways.

Yang M, Yao X, Xia F, Xiang S, Tang W, Zhou B. Yang M, et al. Among authors: yao x. BMC Complement Med Ther. 2024 Jan 12;24(1):36. doi: 10.1186/s12906-024-04336-1. BMC Complement Med Ther. 2024. PMID: 38216941 Free PMC article.

10

Changes in the structural, aggregation behavior and gel properties of pork myofibrillar protein induced by theaflavins.

Nie C, Xiang J, Zheng J, Yao X, Wang W, Tomasevic I, Sun W. Nie C, et al. Among authors: yao x. Food Res Int. 2024 Nov;196:115135. doi: 10.1016/j.foodres.2024.115135. Epub 2024 Sep 25. Food Res Int. 2024. PMID: 39614527

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,224 results

Search Page

Filters